Pharmacological therapy for proliferative vitreoretinopathy
- PMID: 3710177
- DOI: 10.1007/BF02143060
Pharmacological therapy for proliferative vitreoretinopathy
Abstract
We developed an animal model in the rabbit eye with intravitreally injected heterotransplanted bovine retinal pigment epithelial cells to test a pharmacological agent which would reduce extracellular matrix formation. Results with 20 and 60 micrograms of cis-hydroxyproline showed a 48% decrease in the rate of traction retinal detachments.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical